Promising Objective Response Rates and Progression-Free Survival but Modest Overall Survival in the TAB Study

被引：1
|
作者：
Okano, Naohiro [1 ]
Mizutani, Tomonori [1 ]
Hironaka, Shuichi [1 ]
机构：
[1] Kyorin Univ, Fac Med, Dept Med Oncol, Tokyo, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 14期
关键词：
D O I：
10.1200/JCO.23.02726
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Progression-free survival as a surrogate for overall survival in oncology trials: a methodological systematic review
    Lisa Belin
    Aidan Tan
    Yann De Rycke
    Agnès Dechartres
    British Journal of Cancer, 2020, 122 : 1707 - 1714
  • [42] The validity of progression-free survival 2 as a surrogate trial end point for overall survival
    Woodford, Rachel G.
    Zhou, Deborah D. X.
    Kok, Peey-Sei
    Lord, Sally J.
    Friedlander, Michael
    Marschner, Ian C.
    Simes, R. John
    Lee, Chee Khoon
    CANCER, 2022, 128 (07) : 1449 - 1457
  • [43] Rethinking Progression-Free Survival (PFS) as a Clinical Trials Surrogate for Overall Survival (OS)
    Stewart, D.
    Bosse, D.
    Ocana, A.
    Goss, G.
    Jonker, D.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1782 - S1782
  • [44] Progression-Free Survival Versus Overall Survival in Ovarian Cancer: Where Are We Now?
    Banerjee, Susana
    Kaye, Stan
    CURRENT ONCOLOGY REPORTS, 2012, 14 (06) : 483 - 485
  • [45] BOOTSTRAPPING PROGRESSION-FREE SURVIVAL AND OVERALL SURVIVAL TO CAPTURE THEIR CORRELATION IN PROBABILISTIC SENSITIVITY ANALYSES
    van Oostrum, I
    Hu, Y.
    Ouwens, M. J.
    Postma, M. J.
    Buskens, E.
    Heeg, B.
    VALUE IN HEALTH, 2018, 21 : S376 - S376
  • [46] Progression-free survival, overall survival and quality of life: What is their medicoeconomic importance in oncology?
    Pavlovic, Mira
    Garnier, Jerome
    Durand-Zaleski, Isabelle
    Bilbault, Pascal
    Gaudin, Anne-Francoise
    Le Jeunne, Claire
    Lalaude, Olivier
    Roze, Stephane
    de Sahb, Rima
    Sapede, Claudine
    THERAPIE, 2016, 71 (06): : 625 - 632
  • [47] Detecting Overall Survival Benefit Derived From Survival Postprogression Rather Than Progression-Free Survival
    Morita, Satoshi
    Sakamaki, Kentaro
    Yin, Guosheng
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2015, 107 (08):
  • [48] Progression-free survival, post-progression survival, and tumor response as surrogate markers for overall survival in patients with extensive small cell lung cancer
    Imai, Hisao
    Mori, Keita
    Wakuda, Kazushige
    Ono, Akira
    Akamatsu, Hiroaki
    Shukuya, Takehito
    Taira, Tetsuhiko
    Kenmotsu, Hirotsugu
    Naito, Tateaki
    Kaira, Kyoichi
    Murakami, Haruyasu
    Endo, Masahiro
    Nakajima, Takashi
    Yamamoto, Nobuyuki
    Takahashi, Toshiaki
    ANNALS OF THORACIC MEDICINE, 2015, 10 (01) : 61 - 66
  • [49] Correlations between overall response rate, progression-free survival and overall survival in refractory small cell lung cancer treated with lurbinectedin
    Wasifuddin, Mustafa
    Ilerhunmwuwa, Nosakhare Paul
    Hakobyan, Narek
    Tahir, Muhammad
    Abowali, Hesham
    Avezbakiyev, Boris
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [50] Progression Free Survival and Overall Survival in NADIM II Study
    Provencio, M.
    Serna, R.
    Nadal, E.
    Glez Larriba, J. L.
    Martinez-Marti, A.
    Bernabe, R.
    Bosch-Barrera, J.
    Garcia Benito, C.
    Calvo, V.
    Insa, A.
    Ponce, S.
    Reguart, N.
    De Castro, J.
    Massuti, B.
    Palmero, R.
    Aguado de la Rosa, C.
    Mosquera, J.
    Cobo, M.
    Aguilar, A.
    Lopez Vivanco, G.
    Camps, C.
    Hernando Trancho, F.
    Lopez Castro, R.
    Moran, T.
    Barneto, I.
    Rodriguez-Abreu, D.
    Romero, A.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S2 - S3
12345